enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Hypermobility spectrum disorder - Wikipedia

    en.wikipedia.org/wiki/Hypermobility_spectrum...

    Prevalence of HSD alone is unknown, though previous estimates have placed the combined prevalence of hEDS and HSD between 194.2 per 100 000 (0.19%) or 1 in 500 people. [7] The condition is relatively common in those attending musculoskeletal services.

  3. Childhood cancer - Wikipedia

    en.wikipedia.org/wiki/Childhood_cancer

    Cancer in children is rare in the UK, with an average of 1,800 diagnoses every year but contributing to less than 1% of all cancer-related deaths. [70] Age is not a confounding factor in mortality from the disease in the UK. From 2014 to 2016, approximately 230 children died from cancer, with brain/CNS cancers being the most commonly fatal type.

  4. Congenital adrenal hyperplasia due to 3β-hydroxysteroid ...

    en.wikipedia.org/wiki/Congenital_adrenal...

    3β-HSD II mediates three parallel dehydrogenase/isomerase reactions in the adrenals that convert Δ 4 to Δ 5 steroids: pregnenolone to progesterone, 17α-hydroxypregnenolone to 17α-hydroxyprogesterone, and dehydroepiandrosterone (DHEA) to androstenedione. 3β-HSD II also mediates an alternate route of testosterone synthesis from androstenediol in the testes. 3β-HSD deficiency results in ...

  5. Childhood leukemia - Wikipedia

    en.wikipedia.org/wiki/Childhood_Leukemia

    The survival rate for children under the age of 5 years with ALL was 94% during the same time period. [29] Prognostic factors in ALL: Age at diagnosis: Children between the ages of 1–9 years with B-cell ALL (a specific type of ALL) have better cure rates than children less than 1 year old or over 10 years old. This does not seem to matter in ...

  6. Ehlers–Danlos syndrome - Wikipedia

    en.wikipedia.org/wiki/Ehlers–Danlos_syndrome

    While hEDS affects at least one in 5,000 people globally, [1] [14] other types occur at lower frequencies. [ 11 ] [ 8 ] The prognosis depends on the specific disorder. [ 4 ] Excess mobility was first described by Hippocrates in 400 BC. [ 15 ]

  7. Hydroxysteroid dehydrogenase - Wikipedia

    en.wikipedia.org/wiki/Hydroxysteroid_dehydrogenase

    Steroidogenesis. Steroid numbering. Hydroxysteroid dehydrogenases (HSDs) are a group of alcohol oxidoreductases that catalyze the dehydrogenation of hydroxysteroids.These enzymes also catalyze the reverse reaction, acting as ketosteroid reductases (KSRs).

  8. 11β-Hydroxysteroid dehydrogenase - Wikipedia

    en.wikipedia.org/wiki/11β-Hydroxysteroid...

    [9] 10-d hyperlipidemia increases the HSD-11β Type 1 expression in visceral and subcutaneous adipose tissues. [9] Hyperlipidemia decreases HSD-11β Type 2 expression in the liver and adipose tissue. [9] Hyperlipidemia has a great influence on HSD-11β Type 1 and HSD-11β Type 2. [9] This demonstrates that there is likely a relationship between ...

  9. 17β-Hydroxysteroid dehydrogenase III deficiency - Wikipedia

    en.wikipedia.org/wiki/17β-Hydroxysteroid...

    17β-Hydroxysteroid dehydrogenase III deficiency; Other names: 17 alpha ketosteroid reductase deficiency of testis, [1] 46,XY difference of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency, 17-ketoreductase deficiency, 17-ketosteroidreductase deficiency.